Mexico Distribution of COVID-19 in Mexico and obesity comorbidities

Abstract

The COVID-19 pandemic, caused by the SARS-​CoV- 2 virus, began in China in December 2019. The World Health Organization (WHO) declared it a pandemic on March 11, 2020. In Mexico, the first cases were registered in February 2020. On December 31st, 2021, three epidemic waves or peaks were registered, when some cases and deaths had a differentiated space-​time behavior in the national territory, in which comorbidities, as one of the socio-​spatial conditioning factors, also had an influence. The objective of this work is to analyze morbidity and mortality due to SARS-​CoV- 2, caused by the COVID-19 disease, with obesity comorbidities: high blood pressure, diabetes, obesity, and cardiovascular disease, accumulated from the years 2020 and 2021. Methodology. For this research, a literature review was carried out on the role of comorbidities in deaths from COVID-19. The universe of study is Mexico. The spatial disaggregation scale is at the level of the federal entity or state-​owned, with 32 spots. The sources of information are the Daily Technical Communications of the COVID-19 from the Government of Mexico; the Ministry of Health; the General Directorate of Epidemiology (DGE); information from the National Institute of Statistics and Geography (INEG), as well as information from the Geosalud México site. The analysis methods are the implementation of a geographic database, at the state-​owned level, from which tables, maps and the generation of indicators (absolute values, percentages and ratio) were prepared, as well as thematic cartography using GIS software.